Ma Tianyi, Zhang Tiantian, Zhang Le, Zhao Haoming, Liu Ke, Kuang Jianjun, Ou Liang
Hunan University of Chinese Medicine, Changsha, China.
Hunan Academy of Chinese Medicine, 58 Lushan Street, Changsha, 410006, China.
J Orthop Surg Res. 2025 Jan 31;20(1):127. doi: 10.1186/s13018-025-05513-9.
Primary osteoporosis (POP) is a common metabolic bone disorder that has a devastating effect on their quality of life in patients. Acupuncture, a traditional Chinese therapy, has been used to treat osteoporosis for over 2000 years. This study aimed to determine the efficacy of acupuncture in treating POP compared to conventional medicine or placebo.
We searched for potentially relevant studies in PubMed, Web of Science, Embase, Cochrane Central Register of Controlled Trials, China National Knowledge Infrastructure, China Biology Medicine disc, Wanfang database and ClinicalTrials.gov up to December 20, 2024. Randomized controlled trials investigating treatment of POP for which acupuncture was administered as a stand-alone treatment or combined with conventional medicine compared to conventional medicine or placebo, were included. The outcomes included bone mineral density (BMD), visual analogue scale (VAS) scores, clinical effectiveness rate, estradiol (E), Oswestry Disability Index (ODI), and levels of serum alkaline phosphatase (ALP). Data were synthesized using a random-effects meta-analysis model, and the observed heterogeneity was investigated using subgroup analyses. Study quality was appraised using the Cochrane RoB 2 tools, and the quality of the aggregated evidence was evaluated using the GRADE guidelines. Publication bias was assessed by funnel plots and validated by Egger's test.
Forty eligible articles with 2654 participants were identified. Compared to the control group, acupuncture effectively increased the BMD (MD 0.04 [0.03-0.06], P < 0.001, I = 92%), clinical efficacy (RR 1.24 [1.14-1.34], P < 0.001, I = 81%), and levels of E (SMD 0.30 [0.09-0.52], P = 0.006, I = 0%), and reduced the VAS scores (SMD - 1.79 [- 2.29 to - 1.29], P < 0.001, I = 95%). Data on ODI and ALP were insufficient for meta-analysis.
The current evidence suggests that the efficacy of acupuncture in improving the symptoms of POP are encouraging for its use in clinical practice as a physical intervention for patients with POP. However, since the included patients were all from China, there was a risk of sample bias, high-quality multicenter studies in different countries or regions should be conducted in the future.
原发性骨质疏松症(POP)是一种常见的代谢性骨病,对患者的生活质量有严重影响。针灸作为一种中医疗法,治疗骨质疏松症已有2000多年的历史。本研究旨在确定与传统药物或安慰剂相比,针灸治疗POP的疗效。
我们在PubMed、Web of Science、Embase、Cochrane对照试验中央注册库、中国知网、中国生物医学文献数据库、万方数据库和ClinicalTrials.gov中检索截至2024年12月20日的潜在相关研究。纳入了将针灸作为单独治疗或与传统药物联合使用治疗POP,并与传统药物或安慰剂进行比较的随机对照试验。结局指标包括骨密度(BMD)、视觉模拟评分(VAS)、临床有效率、雌二醇(E)、Oswestry功能障碍指数(ODI)和血清碱性磷酸酶(ALP)水平。数据采用随机效应荟萃分析模型进行综合,并通过亚组分析研究观察到的异质性。使用Cochrane RoB 2工具评估研究质量,并使用GRADE指南评估汇总证据的质量。通过漏斗图评估发表偏倚,并通过Egger检验进行验证。
共纳入40篇符合条件的文章,涉及2654名参与者。与对照组相比,针灸有效地提高了骨密度(MD 0.04 [0.03 - 0.可见异质性(I² = 92%),临床疗效(RR 1.24 [1.14 - 1.34],P < 0.001,I² = 81%)和E水平(SMD 0.30 [0.09 - 0.52],P = 0.006,I² = 0%),并降低了VAS评分(SMD -1.79 [-2.29至-1.29],P < 0.001,I² = 95%)。关于ODI和ALP的数据不足以进行荟萃分析。
目前的证据表明,针灸改善POP症状的疗效令人鼓舞,可作为POP患者的一种物理干预措施应用于临床实践。然而,由于纳入的患者均来自中国,存在样本偏倚的风险,未来应在不同国家或地区开展高质量的多中心研究。